Orion Marine Group (ORN)
13.84
+0.21 (1.54%)
Upcoming Events
Latest Headlines
Freedom Broker Starts Orion Marine Group (ORN) at Buy
June 2, 2026 9:19 AM - StreetInsider
ORYZON Initiates Patient Enrollment in IDEAL Phase II Trial of Iadademstat in Essential Thrombocythemia
June 2, 2026 8:01 AM - Globe NewsWire
Form 4 Orion Group Holdings For: May 19 Filed by: LEDFORD ROBERT
May 20, 2026 5:57 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: Smith Quentin P. Jr.
May 20, 2026 5:56 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: Sullivan Mary E
May 20, 2026 5:55 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: SHANFELTER AUSTIN J
May 20, 2026 5:54 PM - SEC Filing
Form 4 Orion Group Holdings For: May 19 Filed by: Caliel Michael J
May 20, 2026 5:53 PM - SEC Filing
Form S-8 Orion Group Holdings
May 20, 2026 5:16 PM - SEC Filing
Form 8-K Orion Group Holdings For: May 19
May 20, 2026 5:04 PM - SEC Filing
Orion Group Holdings Announces Conference Participation
May 18, 2026 7:00 AM - Globe NewsWire
Orion Marine Group (ORN) PT Raised to $19 at JPMorgan
May 15, 2026 3:34 AM - StreetInsider
ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
May 14, 2026 10:47 AM - Globe NewsWire
ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026
May 13, 2026 8:00 AM - Globe NewsWire
Form 4 Orion Group Holdings For: May 05 Filed by: FORAN MARGARET M
May 6, 2026 8:22 PM - SEC Filing
Form 4 Orion Group Holdings For: May 01 Filed by: FORAN MARGARET M
May 4, 2026 6:32 PM - SEC Filing
Form 10-Q Orion Group Holdings For: Mar 31
April 29, 2026 2:37 PM - SEC Filing
Form 8-K Orion Group Holdings For: Apr 28
April 29, 2026 8:35 AM - SEC Filing
ORYZON to Participate in Upcoming Events in May and June
April 29, 2026 8:00 AM - Globe NewsWire
Orion Group Holdings Reports First Quarter 2026 Results
April 28, 2026 4:05 PM - StreetInsider
Form SCHEDULE 13G/A Orion Group Holdings Filed by: WASATCH ADVISORS LP
April 23, 2026 11:52 AM - SEC Filing
Orion Group Holdings to Report First Quarter 2026 Financial Results on Tuesday, April 28, 2026
April 8, 2026 4:05 PM - StreetInsider
Form 4 Orion Group Holdings For: Apr 01 Filed by: Earle Edward Chipman
April 2, 2026 4:07 PM - SEC Filing
Form 4 Orion Group Holdings For: Apr 01 Filed by: Boone Travis J
April 2, 2026 4:06 PM - SEC Filing
Form DEFA14A Orion Group Holdings
April 1, 2026 7:53 AM - SEC Filing
Form DEF 14A Orion Group Holdings For: May 19
April 1, 2026 7:52 AM - SEC Filing
Form ARS Orion Group Holdings For: Dec 31
April 1, 2026 7:49 AM - SEC Filing
Form SCHEDULE 13G/A Orion Group Holdings Filed by: VANGUARD GROUP INC
March 27, 2026 11:07 AM - SEC Filing
ORYZON receives US patent allowance for vafidemstat BPD treatment
March 25, 2026 8:00 AM - StreetInsider
ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance
March 25, 2026 8:00 AM - Globe NewsWire
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
March 23, 2026 8:00 AM - Globe NewsWire
Form 4 Orion Group Holdings For: Mar 20 Filed by: Boone Travis J
March 20, 2026 9:54 PM - SEC Filing
Form 8-K/A Orion Group Holdings For: Mar 16
March 19, 2026 5:07 PM - SEC Filing
Orion Group Holdings secures over $125 million in new contracts
March 19, 2026 4:07 PM - StreetInsider
Orion Group Holdings Announces Over $125 Million in Contract Wins
March 19, 2026 4:05 PM - StreetInsider
Form PRE 14A Orion Group Holdings For: May 19
March 17, 2026 4:53 PM - SEC Filing
Form 8-K Orion Group Holdings For: Mar 16
March 17, 2026 4:14 PM - SEC Filing
Orion Group Holdings board loses two directors, shrinks to six members
March 17, 2026 4:05 PM - StreetInsider
Orion Group Holdings, Inc. Announces Retirement of Two Board Members and Decrease in Board Size
March 17, 2026 4:05 PM - StreetInsider
Form 4 Orion Group Holdings For: Mar 16 Filed by: Earle Edward Chipman
March 17, 2026 8:16 AM - SEC Filing
Form 4 Orion Group Holdings For: Mar 16 Filed by: Boone Travis J
March 17, 2026 8:15 AM - SEC Filing
ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors
March 12, 2026 8:00 AM - Globe NewsWire
Form 4 Orion Group Holdings For: Mar 10 Filed by: Smith Quentin P. Jr.
March 10, 2026 5:44 PM - SEC Filing
Form 4 Orion Group Holdings For: Mar 10 Filed by: SHANFELTER AUSTIN J
March 10, 2026 5:43 PM - SEC Filing
Form 144/A Orion Group Holdings Filed by: SHANFELTER AUSTIN J
March 10, 2026 9:46 AM - SEC Filing
Full Article List